Ebola vaccine - An urgent international priority

New England Journal of Medicine

Volumn 371, Issue 24, 2014, Pages 2249-2251

  Kanapathipillai, Rupa ^a   Restrepo, Ana Maria Henao ^a   Fast, Patricia ^a   Wood, David ^b   Dye, Christopher ^b   Kieny, Marie Paule ^b   Moorthy, Vasee ^b  

^a Journal   (United States)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EBOLA VACCINE;

AFRICA; AFRICAN; ANTIBODY RESPONSE; ANTIBODY TITER; CANADA; CELLULAR IMMUNITY; DRUG EFFICACY; DRUG SAFETY; EBOLA HEMORRHAGIC FEVER; EBOLA VIRUS; EPIDEMIC; HEALTH CARE NEED; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; PHASE 1 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; UNITED STATES; VIRUS STRAIN; WEST AFRICAN; EPIDEMICS; HEMORRHAGIC FEVER, EBOLA; IMMUNOLOGY;

CLINICAL TRIALS, PHASE I AS TOPIC; EBOLA VACCINES; EBOLAVIRUS; EPIDEMICS; HEMORRHAGIC FEVER, EBOLA; HUMANS;

EID: 84911469658     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp1412166     Document Type: Article

References (3)

1. Experimental Ebola vaccines: WHO consultation on Ebola vaccines. Geneva: World Health Organization, October 1, 2014 (http: //who.int/mediacentre/news/ebola/01-october-2014/en/).
2. Stanley DA, Honko AN, Asiedu C, et al. Chimpanzee adenovirus vaccine generates acute and durable protective immunity against Ebolavirus challenge. Nat Med 2014 September 7 (Epub ahead of print).
3. Geisbert TW, Geisbert JB, Leung A, et al. Single-injection vaccine protects nonhuman primates against infection with Marburg virus and three species of Ebola virus. J Virol 2009;83: 7296-304.